(Q46746525)

24 December 2017

title

Effects of raloxifene on body fat distribution and lipid profile in healthy post-menopausal women (English)

1 reference

24 December 2017

author name string

C M Francucci

1

1 reference

24 December 2017

P Daniele

2

1 reference

24 December 2017

N Iori

3

1 reference

24 December 2017

A Camilletti

4

1 reference

24 December 2017

F Massi

5

1 reference

24 December 2017

M Boscaro

6

1 reference

24 December 2017

publication date

1 July 2005

1 reference

24 December 2017

Journal of Endocrinological Investigation

published in

1 reference

24 December 2017

volume

28

1 reference

24 December 2017

issue

7

1 reference

24 December 2017

page(s)

623-631

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1007/bf03347261

exact match

0 references

cites work

Coronary heart disease: an older woman's major health risk

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Influence of age and menopause on serum lipids and lipoproteins in healthy women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Changes in energy balance and body composition at menopause: a controlled longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Hormone replacement therapy and endometrial cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Estrogen and the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Raloxifene and estrogen reduces progression of advanced atherosclerosis--a study in ovariectomized, cholesterol-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Estrogen and coronary heart disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Estrogen and homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Fat cell metabolism in different regions in women. Effect of menstrual cycle, pregnancy, and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Metabolism of mammary, abdominal, and femoral adipocytes in women before and after menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Raloxifene versus continuous combined estrogen/progestin therapy: densitometric and biochemical effects in healthy postmenopausal Taiwanese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Randomized control study of the effects of raloxifene on serum lipids and homocysteine in older women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Effects of raloxifene and hormone replacement therapy on markers of serum atherogenicity in healthy postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Associated response in bone mineral density and atherogenic lipid profile during treatment with two different selective estrogen receptor modulators: levormeloxifene and raloxifene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Efficacy and safety of raloxifene 60 milligrams/day in postmenopausal Asian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Post hoc analysis of data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial on the effects of three years of raloxifene treatment on glycemic control and cardiovascular disease risk factors in women with and without type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Raloxifene does not modify insulin sensitivity and glucose metabolism in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Dyslipidemia, gender, and the role of high-density lipoprotein cholesterol: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

The effect of raloxifene on glyco-insulinemic homeostasis in healthy postmenopausal women: a randomized placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Differential effects of raloxifene and estrogen on insulin sensitivity in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347261

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

21 January 2018

1 reference

12 December 2020

The effect of menopause on blood lipid and lipoprotein levels. The Icarus Study Group

1 reference

12 December 2020

Measurement of cholesterol and other lipoprotein constituents in the clinical laboratory

1 reference

12 December 2020

From presumed benefit to potential harm--hormone therapy and heart disease

1 reference

12 December 2020

Human body composition: in vivo methods

1 reference

12 December 2020

Treatment of established postmenopausal osteoporosis with raloxifene: a randomized trial

1 reference

12 December 2020

Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome

1 reference

12 December 2020

Raloxifene does not affect insulin sensitivity or glycemic control in postmenopausal women with type 2 diabetes mellitus: a randomized clinical trial

1 reference

12 December 2020

Measurement of abdominal and visceral fat with computed tomography and dual-energy x-ray absorptiometry

1 reference

12 December 2020

Relative contribution of aging and menopause to changes in lean and fat mass in segmental regions

1 reference

12 December 2020

Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal women.

1 reference

12 December 2020

Body weight, fat distribution and the menopausal status in women. The VMH Collaborative Group

1 reference

12 December 2020

Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women

1 reference

12 December 2020

Dyslipidemia of central obesity and insulin resistance.

1 reference

12 December 2020

Relationships between abdominal body fat distribution and cardiovascular risk factors: an explanation for women's healthier cardiovascular risk profile. The D.E.S.I.R. Study

1 reference

12 December 2020

Hypocholesterolemic activity of raloxifene (LY139481): pharmacological characterization as a selective estrogen receptor modulator

1 reference

12 December 2020

Menopause and risk factors for coronary heart disease

1 reference

12 December 2020

Adipose tissue distribution measured by magnetic resonance imaging in obese women

1 reference

12 December 2020

Long-term fracture prediction by bone mineral assessed at different skeletal sites

1 reference

12 December 2020

Effect of menopausal status on body composition and abdominal fat distribution

1 reference

12 December 2020

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03347261

1 reference

24 December 2017

1 reference

24 December 2017